tion Gonococcal Treatment Guidelines Among Chicago Health Care Providers, 2011–2012

• Published in: Sexually transmitted diseases 2015-08, Vol.42 (8), p.422-428
• Main Authors: Tabidze, Irina L, Nicholson, Tracy F, Mikati, Tarek, Benbow, Nanette, Mehta, Supriya D
• Format: Article
• Language: English
• ISSN: 0148-5717; 1537-4521
• DOI: 10.1097/OLQ.0000000000000310

BACKGROUNDExpansion of antimicrobial resistance in Neisseria gonorrhoeae requires rapid adaptation of treatment guidelines and responsive provider practice. We evaluated patient factors associated with provider adherence to the Centers for Disease Control and Prevention gonococcal treatment recommendations among Chicago providers in 2011 to 2012. METHODSLaboratory-confirmed cases of uncomplicated urogenital gonorrhea were classified via surveillance data as originating from Chicago Department of Public Health (CDPH) or non-CDPH providers. Recommended treatment was determined according to the Centers for Disease Control and Prevention sexually transmitted disease treatment guidelinesApril 2011–July 2012 (period 1) and August–December 2012 (period 2, after August 2012 revision). Multivariable log-binomial regression identified factors associated with recommended treatment over time, stratified by provider type. RESULTSApril 2011 through December 2012, 16,646 laboratory-confirmed gonorrhea cases were identified, of which 9597 (57.7%) had treatment information2169 CDPH cases and 7428 non-CDPH cases. Documented recommended treatment increased for CDPH (period 171.3%, period 280.8%; P < 0.01) and non-CDPH providers (period 163.5%, period 268.9%; P < 0.01). Among CDPH cases, statistically significant factors associated with recommended treatment were male sex (adjusted prevalence rate ratio [aPRR], 1.16) white versus black race (aPRR, 0.68), same-day treatment (aPRR, 1.07), and period 2 (aPRR, 1.11). Among non-CDPH cases, statistically significant factors were as followsmale sex (aPRR, 1.10), other versus black race (aPRR, 0.91), same-day treatment (aPRR, 1.31), greater number of within-facility reported cases (aPRRs ranging from 1.22 to 1.41), and at least 50% within-facility missing treatment data (aPRR, 0.84). CONCLUSIONSRecommended treatment improved over time, yet remains suboptimal. Efforts to reduce variability and improve provider adherence to recommended treatment are urgently needed.